Golden State Wealth Management’s Ionis Pharmaceuticals IONS Stock Holding History

Golden State Wealth Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$29.8K	Hold	376	–	–	﹤0.01%	862
2026 Q1	$28.2K	Hold	376	–	–	﹤0.01%	828
2025 Q4	$29.7K	Hold	376	–	–	﹤0.01%	824
2025 Q3	$24.6K	Buy	376 +250	+198%	+$12.2K	﹤0.01%	864
2025 Q2	$4.98K	Hold	126	–	–	﹤0.01%	1228
2025 Q1	$3.8K	Hold	126	–	–	﹤0.01%	1223
2024 Q4	$4.41K	Buy	+126	New	+$4.71K	﹤0.01%	1138
2020 Q2	–	Sell	-126	Closed	-$6K	–	585
2020 Q1	$6K	Buy	+126	New	+$7.02K	﹤0.01%	708
2019 Q4	–	Sell	-126	Closed	-$8K	–	483
2019 Q3	$8K	Sell	126 -120	-49%	-$7.82K	﹤0.01%	786
2019 Q2	$15K	Buy	246 +120	+95%	+$8.48K	﹤0.01%	667
2019 Q1	$10K	Buy	+126	New	+$8.13K	﹤0.01%	777

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Golden State Wealth Management's IONS Position: Q2 2026 in Review

Golden State Wealth Management held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 376 shares worth $29.8K. The position accounts for ﹤0.01% of the portfolio, ranked #862.

Golden State Wealth Management first reported a position in IONS in Q1 2019 and has held it in 11 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Golden State Wealth Management held 376 shares of Ionis Pharmaceuticals worth $29.8K as of Q2 2026.
Golden State Wealth Management left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
Ionis Pharmaceuticals made up ﹤0.01% of Golden State Wealth Management's portfolio in Q2 2026, its #862 holding.
Golden State Wealth Management first reported a position in Ionis Pharmaceuticals in Q1 2019 and has held it in 11 quarters since.
514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.